Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Moore John R
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Array BioPharma, Inc.
Edgewise Therapeutics, Inc.
Nivalis Therapeutics, Inc.
Array BioPharma, Inc.
VP, General Counsel
Avg. Two Year Performance
No Purchase Track Record
27%
Avg. Sale Return
13%
Compound
Holdings:
42.06K
shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Other
Other
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions